Thursday, July 28, 2005 5:53:27 PM
"Clinical Trials Enrolling as of July 28, 2005
Product Location Principal
Investigator Indication Phase Contact
Panzem® NCD
Press Release University of Wisconsin Comprehensive Cancer Center (UWCCC), Madison, WI Dr. George Wilding Advanced Cancer Ib Cancer Connect: Patient and Physician
Resource:
1- 800-622-8922 or (608) 262-5223
UWCCC
600 Highland Avenue, K4/6 Madison,
WI 53792-6164
Indiana University Cancer Center, Indianapolis, IN Dr. Christopher J. Sweeney http://iucc.iu.edu "
Good luck and God bless,
George
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM